annual accounts payable:
$58.30M+$19.82M(+51.53%)Summary
- As of today (September 17, 2025), TGTX annual accounts payable is $58.30 million, with the most recent change of +$19.82 million (+51.53%) on December 31, 2024.
- During the last 3 years, TGTX annual accounts payable has risen by +$7.00 million (+13.65%).
- TGTX annual accounts payable is now at all-time high.
Performance
TGTX Accounts payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly accounts payable:
$134.02M+$89.00K(+0.07%)Summary
- As of today (September 17, 2025), TGTX quarterly accounts payable is $134.02 million, with the most recent change of +$89.00 thousand (+0.07%) on June 30, 2025.
- Over the past year, TGTX quarterly accounts payable has increased by +$40.55 million (+43.38%).
- TGTX quarterly accounts payable is now at all-time high.
Performance
TGTX quarterly accounts payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
TGTX Accounts payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +51.5% | +43.4% |
| 3 y3 years | +13.7% | +260.0% |
| 5 y5 years | +94.0% | +351.7% |
TGTX Accounts payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +51.5% | at high | +350.9% |
| 5 y | 5-year | at high | +94.0% | at high | +351.7% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
TGTX Accounts payable History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $134.02M(+0.1%) |
| Mar 2025 | - | $133.93M(+129.7%) |
| Dec 2024 | $58.30M(+51.5%) | $58.30M(-42.5%) |
| Sep 2024 | - | $101.41M(+8.5%) |
| Jun 2024 | - | $93.47M(+7.1%) |
| Mar 2024 | - | $87.27M(+126.8%) |
| Dec 2023 | $38.47M(-8.4%) | $38.47M(-3.2%) |
| Sep 2023 | - | $39.74M(-36.9%) |
| Jun 2023 | - | $62.95M(+10.3%) |
| Mar 2023 | - | $57.09M(+35.9%) |
| Dec 2022 | $42.02M(-18.1%) | $42.02M(+41.4%) |
| Sep 2022 | - | $29.73M(-20.1%) |
| Jun 2022 | - | $37.22M(-25.1%) |
| Mar 2022 | - | $49.67M(-3.2%) |
| Dec 2021 | $51.29M(+38.6%) | $51.29M(+14.7%) |
| Sep 2021 | - | $44.70M(+11.1%) |
| Jun 2021 | - | $40.23M(-6.1%) |
| Mar 2021 | - | $42.84M(+15.7%) |
| Dec 2020 | $37.01M(+23.2%) | $37.01M(+6.8%) |
| Sep 2020 | - | $34.66M(+16.8%) |
| Jun 2020 | - | $29.67M(-4.0%) |
| Mar 2020 | - | $30.90M(+2.9%) |
| Dec 2019 | $30.04M(-17.4%) | $30.04M(-5.5%) |
| Sep 2019 | - | $31.78M(+0.9%) |
| Jun 2019 | - | $31.50M(-20.1%) |
| Mar 2019 | - | $39.40M(+8.3%) |
| Dec 2018 | $36.38M(+40.6%) | $36.38M(-4.1%) |
| Sep 2018 | - | $37.92M(+7.1%) |
| Jun 2018 | - | $35.39M(+8.9%) |
| Mar 2018 | - | $32.51M(+25.6%) |
| Dec 2017 | $25.88M(+69.5%) | $25.88M(+42.3%) |
| Sep 2017 | - | $18.18M(-7.0%) |
| Jun 2017 | - | $19.56M(+3.4%) |
| Mar 2017 | - | $18.92M(+23.9%) |
| Dec 2016 | $15.27M(+63.4%) | $15.27M(-1.8%) |
| Sep 2016 | - | $15.55M(+18.9%) |
| Jun 2016 | - | $13.08M(+62.7%) |
| Mar 2016 | - | $8.04M(-14.0%) |
| Dec 2015 | $9.35M(+134.1%) | $9.35M(+8.9%) |
| Sep 2015 | - | $8.58M(+4.0%) |
| Jun 2015 | - | $8.25M(-7.1%) |
| Mar 2015 | - | $8.88M(+122.5%) |
| Dec 2014 | $3.99M(-16.2%) | $3.99M(-49.9%) |
| Sep 2014 | - | $7.97M(+319.5%) |
| Jun 2014 | - | $1.90M(+15.9%) |
| Mar 2014 | - | $1.64M(-65.6%) |
| Dec 2013 | $4.76M(+326.4%) | $4.76M(+10.2%) |
| Sep 2013 | - | $4.33M(+92.4%) |
| Jun 2013 | - | $2.25M(+61.9%) |
| Mar 2013 | - | $1.39M(+24.2%) |
| Dec 2012 | $1.12M | $1.12M(+199.8%) |
| Sep 2012 | - | $372.70K(+15.9%) |
| Jun 2012 | - | $321.70K(-31.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2012 | - | $467.50K(-29.9%) |
| Dec 2011 | $666.60K(+198.3%) | $666.60K(+297.5%) |
| Sep 2011 | - | $167.70K(-19.2%) |
| Jun 2011 | - | $207.60K(+13.3%) |
| Mar 2011 | - | $183.30K(-18.0%) |
| Dec 2010 | $223.50K(+3.8%) | $223.50K(-43.5%) |
| Sep 2010 | - | $395.80K(+5.9%) |
| Jun 2010 | - | $373.80K(+23.5%) |
| Mar 2010 | - | $302.70K(+40.5%) |
| Dec 2009 | $215.40K(-60.3%) | $215.40K(+50.5%) |
| Sep 2009 | - | $143.10K(-17.2%) |
| Jun 2009 | - | $172.90K(+19.7%) |
| Mar 2009 | - | $144.50K(-73.4%) |
| Dec 2008 | $542.30K(-57.6%) | $542.30K(-23.1%) |
| Sep 2008 | - | $705.30K(+14.3%) |
| Jun 2008 | - | $617.30K(-37.4%) |
| Mar 2008 | - | $986.20K(-22.9%) |
| Dec 2007 | $1.28M(-8.2%) | $1.28M(+50.1%) |
| Sep 2007 | - | $852.50K(-14.9%) |
| Jun 2007 | - | $1.00M(-34.3%) |
| Mar 2007 | - | $1.52M(+9.4%) |
| Dec 2006 | $1.39M(-13.9%) | $1.39M(+28.4%) |
| Sep 2006 | - | $1.09M(-44.7%) |
| Jun 2006 | - | $1.96M(-1.4%) |
| Mar 2006 | - | $1.99M(+23.1%) |
| Dec 2005 | $1.62M(+41.4%) | $1.62M(-5.6%) |
| Sep 2005 | - | $1.71M(+31.5%) |
| Jun 2005 | - | $1.30M(+17.2%) |
| Mar 2005 | - | $1.11M(-2.8%) |
| Dec 2004 | $1.14M(+108.5%) | $1.14M(-17.5%) |
| Sep 2004 | - | $1.39M(+235.3%) |
| Jun 2004 | - | $413.50K(-27.4%) |
| Mar 2004 | - | $569.40K(+3.8%) |
| Dec 2003 | $548.60K(-5.0%) | $548.60K(-27.9%) |
| Sep 2003 | - | $760.50K(+32.5%) |
| Jun 2003 | - | $574.00K(+21.2%) |
| Mar 2003 | - | $473.70K(-18.0%) |
| Dec 2002 | $577.70K(+13.7%) | $577.70K(+14.6%) |
| Sep 2002 | - | $504.00K(+17.8%) |
| Jun 2002 | - | $427.70K(-11.8%) |
| Mar 2002 | - | $485.00K(-4.5%) |
| Dec 2001 | $508.00K(-35.4%) | $508.00K(-32.1%) |
| Sep 2001 | - | $748.40K(+5.9%) |
| Jun 2001 | - | $706.90K(-9.3%) |
| Mar 2001 | - | $779.20K(-0.9%) |
| Dec 2000 | $786.00K(+44.8%) | $786.00K(-26.0%) |
| Sep 2000 | - | $1.06M(+95.7%) |
| Jun 2000 | - | $542.50K(+9.4%) |
| Mar 2000 | - | $495.90K(-8.6%) |
| Dec 1999 | $542.80K | $542.80K(>+9900.0%) |
| Sep 1998 | - | $0.00(0.0%) |
| Jun 1998 | - | $0.00(0.0%) |
| Mar 1998 | - | $0.00 |
FAQ
- What is TG Therapeutics, Inc. annual accounts payable?
- What is the all time high annual accounts payable for TG Therapeutics, Inc.?
- What is TG Therapeutics, Inc. annual accounts payable year-on-year change?
- What is TG Therapeutics, Inc. quarterly accounts payable?
- What is the all time high quarterly accounts payable for TG Therapeutics, Inc.?
- What is TG Therapeutics, Inc. quarterly accounts payable year-on-year change?
What is TG Therapeutics, Inc. annual accounts payable?
The current annual accounts payable of TGTX is $58.30M
What is the all time high annual accounts payable for TG Therapeutics, Inc.?
TG Therapeutics, Inc. all-time high annual accounts payable is $58.30M
What is TG Therapeutics, Inc. annual accounts payable year-on-year change?
Over the past year, TGTX annual accounts payable has changed by +$19.82M (+51.53%)
What is TG Therapeutics, Inc. quarterly accounts payable?
The current quarterly accounts payable of TGTX is $134.02M
What is the all time high quarterly accounts payable for TG Therapeutics, Inc.?
TG Therapeutics, Inc. all-time high quarterly accounts payable is $134.02M
What is TG Therapeutics, Inc. quarterly accounts payable year-on-year change?
Over the past year, TGTX quarterly accounts payable has changed by +$40.55M (+43.38%)